These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 16570679)
1. Usefulness of an observational database to assess antiretroviral treatment trends in India. Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679 [TBL] [Abstract][Full Text] [Related]
2. Trends in perimortal conditions and mortality rates among HIV-infected patients. Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral drug therapy in HIV-infected Jamaican children. Evans-Gilbert T; Pierre R; Steel-Duncan JC; Rodriguez B; Whorms S; Hambleton IR; Figueroa JP; Christie CD West Indian Med J; 2004 Oct; 53(5):322-6. PubMed ID: 15675498 [TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069 [TBL] [Abstract][Full Text] [Related]
5. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy. Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064 [TBL] [Abstract][Full Text] [Related]
6. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Kumarasamy N; Solomon S; Chaguturu SK; Cecelia AJ; Vallabhaneni S; Flanigan TP; Mayer KH Clin Infect Dis; 2005 Nov; 41(10):1525-8. PubMed ID: 16231268 [TBL] [Abstract][Full Text] [Related]
7. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients. Ortega KL; Vale DA; Magalhães MH J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845 [TBL] [Abstract][Full Text] [Related]
8. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study. Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U; Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519 [TBL] [Abstract][Full Text] [Related]
9. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico. Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946 [TBL] [Abstract][Full Text] [Related]
10. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders. Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200 [TBL] [Abstract][Full Text] [Related]
12. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme. Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS HIV Med; 2007 Mar; 8(2):80-5. PubMed ID: 17352763 [TBL] [Abstract][Full Text] [Related]
13. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787 [TBL] [Abstract][Full Text] [Related]
14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567 [TBL] [Abstract][Full Text] [Related]
15. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database. Zhou J; Paton NI; Ditangco R Int J STD AIDS; 2007 Jul; 18(7):446-52. PubMed ID: 17623500 [TBL] [Abstract][Full Text] [Related]
16. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
17. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance. Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981 [TBL] [Abstract][Full Text] [Related]
18. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260 [TBL] [Abstract][Full Text] [Related]
19. The natural history of human immunodeficiency virus infection among adults in Mumbai. Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853 [TBL] [Abstract][Full Text] [Related]
20. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience. Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]